Lung cancer survey reveals top treatment priorities for patients and doctors
NCT ID NCT07413757
First seen Feb 24, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study uses a survey to find out what Chinese patients and doctors consider most important when choosing a first-line targeted therapy for advanced non-small cell lung cancer. About 590 participants (patients and physicians) will answer questions about treatment preferences, such as side effects and effectiveness. The goal is to better understand decision-making, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGChengdu, 610000, China
Conditions
Explore the condition pages connected to this study.